Publications in collaboration with researchers from Centro de Investigación en Red en Enfermedades Cardiovasculares (23)

2022

  1. Minimal invasive fluorescence methods to quantify advanced glycation end products (AGEs) in skin and plasma of humans

    Methods, Vol. 203, pp. 103-107

2021

  1. Biocompatibility analysis of thermal and UV-curable polydimethylsiloxane for semi blood vessel-like model fabrication

    2021 Conference on Lasers and Electro-Optics Europe and European Quantum Electronics Conference, CLEO/Europe-EQEC 2021

  2. Biocompatibility analysis of thermal and UV-curable polydimethylsiloxane for semi blood vessel-like model fabrication

    Optics InfoBase Conference Papers

  3. Correction to: Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling (Journal of Molecular Medicine, (2021), 99, 7, (943-953), 10.1007/s00109-021-02054-6)

    Journal of Molecular Medicine

  4. Galectin-3 and soluble RAGE as new biomarkers of post-infarction cardiac remodeling

    Journal of Molecular Medicine, Vol. 99, Núm. 7, pp. 943-953

  5. Haemodynamic-dependent arrest of circulating tumour cells at large blood vessel bifurcations as new model for metastasis

    Scientific Reports, Vol. 11, Núm. 1

  6. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  7. Microfluidic devices manufacturing with a stereolithographic printer for biological applications

    Materials Science and Engineering C, Vol. 129

  8. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

2020

  1. Antirhea borbonica aqueous extract protects albumin and erythrocytes from glycoxidative damages

    Antioxidants, Vol. 9, Núm. 5

  2. Edoxaban's contribution to key endothelial cell functions

    Biochemical Pharmacology, Vol. 178

  3. First-Days Reduction of Plasma and Skin Advanced Glycation End Products is Related to Outcome in Septic Patients

    Shock, Vol. 53, Núm. 4, pp. 400-406

2019

  1. Advanced glycation end-products disrupt human endothelial cells redox homeostasis: new insights into reactive oxygen species production

    Free Radical Research, Vol. 53, Núm. 2, pp. 150-169

  2. Inflammatory effects of in vivo glycated albumin from cardiovascular patients

    Biomedicine and Pharmacotherapy, Vol. 113

  3. Obesity-Related Genetic Determinants of Heart Failure Prognosis

    Cardiovascular Drugs and Therapy, Vol. 33, Núm. 4, pp. 415-424

  4. The different roles for the advanced glycation end products axis in heart failure and acute coronary syndrome settings

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 29, Núm. 10, pp. 1050-1060

2018

  1. Determination of hemodynamic risk for vascular disease in planar artery bifurcations

    Scientific Reports, Vol. 8, Núm. 1

  2. Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide

    Journal of Biological Chemistry, Vol. 293, Núm. 13, pp. 4778-4791

  3. Protective, repairing and fibrinolytic effects of rivaroxaban on vascular endothelium

    British Journal of Clinical Pharmacology, Vol. 84, Núm. 2, pp. 280-291

2017

  1. Evolution and bad prognostic value of advanced glycation end products after acute heart failure: Relation with body composition

    Cardiovascular Diabetology, Vol. 16, Núm. 1